Provid Pharmaceuticals of New Jersey and Acesys Pharmatech of China have formed a US-China CRO alliance. The new group puts together Provid’s US-based drug discovery expertise and project management capabilities with Acesys’s China-based medicinal chemistry resources and favorable cost structure. According to the announcement, the alliance will offer all aspects of medicinal chemistry for pharmaceutical and biotech clients. More details...

Stock Symbols: (HKEX: 2285) (NSDQ: CBTE) (NYSE: SGP) (NYSE: MRK)